These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 3940336)

  • 1. Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
    Hess LW; Anderson RL; Golbus MS
    Obstet Gynecol; 1986 Jan; 67(1):44-6. PubMed ID: 3940336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis.
    Hankins GD; Rowe J; Quirk JG; Trubey R; Strickland DM
    Obstet Gynecol; 1984 Sep; 64(3):353-8. PubMed ID: 6205335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The distinction of elevated alpha-fetoprotein levels in amniotic fluids for antenatal diagnosis of genetic defects].
    Hemke G; Weise W; Düker D
    Z Geburtshilfe Perinatol; 1982; 186(3):133-5. PubMed ID: 6181623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meconium staining of amniotic fluid at midtrimester amniocentesis.
    Karp LE; Schiller HS
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):47s-49s. PubMed ID: 876542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discolored amniotic fluid--results of prenatal diagnosis and clinical significance].
    Gnirs J; Boos R; Hendrik J; Hentemann M; Schmidt W
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):217-22. PubMed ID: 1711490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis.
    Elejalde BR; de Elejalde MM; Acuña JM; Thelen D; Trujillo C; Karrmann M
    Am J Med Genet; 1990 Feb; 35(2):188-96. PubMed ID: 2309757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
    Vrachnis N; Malamitsi-Puchner A; Samoli E; Botsis D; Iliodromiti Z; Baka S; Hassiakos D; Creatsas G
    J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth.
    Malamitsi-Puchner A; Vrachnis N; Samoli E; Baka S; Hassiakos D; Creatsas G
    J Soc Gynecol Investig; 2006 Jan; 13(1):25-9. PubMed ID: 16378910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of pregnancy following amniocentesis in the prenatal diagnosis of genetic birth defects].
    Schlensker KH; Citoler P; Bolte A
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):137-45. PubMed ID: 6562979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery.
    Apuzzio J; Chan Y; Al-Khan A; Illsley N; Kim PL; Vonhaggen S
    J Matern Fetal Neonatal Med; 2004 May; 15(5):313-7. PubMed ID: 15280122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome.
    Nguyen DP; Gerber S; Hohlfeld P; Sandrine G; Witkin SS
    J Perinat Med; 2004; 32(4):323-6. PubMed ID: 15346817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal diagnosis after abortus imminens--further progress of pregnancy and peculiarity of amniotic cell cultivation (author's transl)].
    Wurster KG; Jonatha W; Knörr-Gärtner H
    Geburtshilfe Frauenheilkd; 1979 Mar; 39(3):222-7. PubMed ID: 86478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].
    Winter R
    Wien Klin Wochenschr; 1983 Feb; 95(3):67-78. PubMed ID: 6190319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformations.
    Kolho KL; Kuusela P; Heikinheimo M; Jalanko H
    Scand J Clin Lab Invest; 1983 Dec; 43(8):687-90. PubMed ID: 6198712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.